ATC Group: H02BX01 Methylprednisolone, combinations

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of H02BX01 in the ATC hierarchy

Level Code Title
1 H Systemic hormonal preparations, excl. Sex hormones and insulins
2 H02 Corticosteroids for systemic use
3 H02B CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
4 H02BX Corticosteroids for systemic use, combinations
5 H02BX01 Methylprednisolone, combinations

Related product monographs

Title Information Source Document Type  
DEPO-MEDRONE WITH LIDOCAINE Suspension for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

Canada (CA)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Netherlands (NL)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.